publication . Other literature type . Article . 2006

Bronchiectasis in Rheumatoid Arthritis: Report of Four Cases and a Review of the Literature—Implications for Management with Biologic Response Modifiers

Edward V. Lally; Irene M. Orzano; Michael A. Passero; Lori Lieberman-Maran;
  • Published: 01 Jun 2006
  • Publisher: Elsevier BV
OBJECTIVE To describe patients with rheumatoid arthritis (RA) who subsequently developed bronchiectasis (BR) and to review the literature on biologic response modifiers (BRM) in relation to infectious complications in the management of these patients. METHODS We describe 4 patients with RA who were diagnosed with BR out of a cohort of 170 patients. We then performed a comprehensive review of the English language literature on the major clinical trials for RA that involved the BRMs etanercept, infliximab, anakinra, and adalimumab. We focused on inclusion/exclusion criteria involving pulmonary disease and infectious complications in these trials. RESULTS Of the 4 ...
free text keywords: Immunology, Adalimumab, medicine.drug, medicine, Internal medicine, medicine.medical_specialty, Etanercept, Clinical trial, Rheumatoid arthritis, medicine.disease, Anakinra, business.industry, business, Cohort, Bronchiectasis, Infliximab
Related Organizations
Any information missing or wrong?Report an Issue